Work

Efficacy ans safety of mepolizumab in hypereosinophilic syndrome: a Phase III, randomized, placebo-controlled trial

Year: 2021

Type: conference-paper

Source: Pneumologie

DOI: 10.1055/s-0041-1723351

Authors: J Steinfeld, F Roufosse, J E Kahn, G J Gleich, M E Rothenberg, A J Wardlaw, S Y Kirby, M Gilson, J H Bentley, E S Bradford, S W Yancey

Institutions: GlaxoSmithKline (United States), Université Libre de Bruxelles, Erasmus Hospital, Université de Versailles Saint-Quentin-en-Yvelines, Hôpital Ambroise-Paré, University of Utah, Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Leicester, GlaxoSmithKline (United Kingdom)

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3195627565

FWCI:

Cites:

Cited by: 1

Related to: 10